FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109413201> ?p ?o ?g. }

• W2109413201 endingPage "2019" @default.
• W2109413201 startingPage "2019" @default.
• W2109413201 abstract "As a Clinical Associate in the Pharmacology Section in the National Cancer Institute in 1967, virtually all of the patients referred to me had far-advanced, metastatic cancers, whether of the breast, colon, prostate, or lung. Treatment choices for disseminated disease were limited to a half dozen Food and Drug Administration–approved cytotoxic agents and another half dozen experimental drugs. Five-year survival rates for all cancers were in the mid-30 percent range and cure rates were virtually nonexistent. Cancer survivorship, as a clinically relevant problem, was 30 to 40 years away, and cancer prevention was a nonexistent field of research. In fact, 4 years later, in 1971, at the time of the establishment of the National Cancer Act, it was estimated that there were only a total of three million cancer survivors in the United States (1).Fast forward 35 years and the total number of cancer survivors in the United States is estimated to have increased ∼4-fold with incremental yearly increases of 2%. Now, cancer survivors represent >3.5% of the U.S. population, with the addition of one million new survivors each year (2). With dramatically improved molecularly-targeted therapies, markedly enhanced screening technologies, and the development of effective secondary prevention strategies, 5-year survival rates have risen into the mid-60 percent range. Suddenly, cancer survivors are everywhere and pose an increasing health care problem, related to both the late effects of cancer treatment and the strong threat of second primary cancers. In fact, second or multiple primary cancers in cancer survivors represent 16% of all new primary cancers.A comprehensive research effort is needed to address increasingly complex issues of cancer survivorship, especially with respect to the extremely high rate of second cancers. This increasingly large and high-risk population represents an outstanding opportunity for novel cancer screening strategies, the development of targeted chemopreventive agents and vaccines, as well as more sensitive and precise biomarkers of risk and early detection. In this special section of Cancer Epidemiology, Biomarkers, and Prevention are presented articles from Drs. Lois Travis, Susan Mayne, and Victor Vogel, who participated as invited speakers in an American Society of Oncology/AACR-sponsored mini symposium entitled “Second Cancers Are Killing Us!” at the AACR's Frontiers in Cancer Prevention fourth annual meeting in Baltimore, MD in November, 2005. It is anticipated that these three articles, covering the epidemiology, screening, and chemoprevention of second primary cancers will serve to ignite interest in multiple research areas about the long-term follow up and management of the ever increasing population of cancer survivors in the United States." @default.
• W2109413201 created "2016-06-24" @default.
• W2109413201 creator A5029541691 @default.
• W2109413201 date "2006-11-01" @default.
• W2109413201 modified "2023-10-16" @default.
• W2109413201 title "Second Cancers Are Killing Us!" @default.
• W2109413201 cites W2134021476 @default.
• W2109413201 doi "https://doi.org/10.1158/1055-9965.epi-06-0417" @default.
• W2109413201 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17057025" @default.
• W2109413201 hasPublicationYear "2006" @default.
• W2109413201 type Work @default.
• W2109413201 sameAs 2109413201 @default.
• W2109413201 citedByCount "18" @default.
• W2109413201 countsByYear W21094132012013 @default.
• W2109413201 countsByYear W21094132012014 @default.
• W2109413201 countsByYear W21094132012016 @default.
• W2109413201 countsByYear W21094132012017 @default.
• W2109413201 countsByYear W21094132012021 @default.
• W2109413201 countsByYear W21094132012023 @default.
• W2109413201 crossrefType "journal-article" @default.
• W2109413201 hasAuthorship W2109413201A5029541691 @default.
• W2109413201 hasBestOaLocation W21094132011 @default.
• W2109413201 hasConcept C121608353 @default.
• W2109413201 hasConcept C126322002 @default.
• W2109413201 hasConcept C143998085 @default.
• W2109413201 hasConcept C172400760 @default.
• W2109413201 hasConcept C2776256026 @default.
• W2109413201 hasConcept C2778527826 @default.
• W2109413201 hasConcept C2780192828 @default.
• W2109413201 hasConcept C2780558122 @default.
• W2109413201 hasConcept C2908647359 @default.
• W2109413201 hasConcept C530470458 @default.
• W2109413201 hasConcept C71924100 @default.
• W2109413201 hasConcept C99454951 @default.
• W2109413201 hasConceptScore W2109413201C121608353 @default.
• W2109413201 hasConceptScore W2109413201C126322002 @default.
• W2109413201 hasConceptScore W2109413201C143998085 @default.
• W2109413201 hasConceptScore W2109413201C172400760 @default.
• W2109413201 hasConceptScore W2109413201C2776256026 @default.
• W2109413201 hasConceptScore W2109413201C2778527826 @default.
• W2109413201 hasConceptScore W2109413201C2780192828 @default.
• W2109413201 hasConceptScore W2109413201C2780558122 @default.
• W2109413201 hasConceptScore W2109413201C2908647359 @default.
• W2109413201 hasConceptScore W2109413201C530470458 @default.
• W2109413201 hasConceptScore W2109413201C71924100 @default.
• W2109413201 hasConceptScore W2109413201C99454951 @default.
• W2109413201 hasIssue "11" @default.
• W2109413201 hasLocation W21094132011 @default.
• W2109413201 hasLocation W21094132012 @default.
• W2109413201 hasOpenAccess W2109413201 @default.
• W2109413201 hasPrimaryLocation W21094132011 @default.
• W2109413201 hasRelatedWork W122560183 @default.
• W2109413201 hasRelatedWork W2004846284 @default.
• W2109413201 hasRelatedWork W2224319365 @default.
• W2109413201 hasRelatedWork W2294069589 @default.
• W2109413201 hasRelatedWork W2766672491 @default.
• W2109413201 hasRelatedWork W2887621906 @default.
• W2109413201 hasRelatedWork W2890859100 @default.
• W2109413201 hasRelatedWork W333353396 @default.
• W2109413201 hasRelatedWork W377899687 @default.
• W2109413201 hasRelatedWork W4235380988 @default.
• W2109413201 hasVolume "15" @default.
• W2109413201 isParatext "false" @default.
• W2109413201 isRetracted "false" @default.
• W2109413201 magId "2109413201" @default.
• W2109413201 workType "article" @default.